Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, John P. Leonard, Sonali M. Smith et al.|Blood|2021Cited by 37
Iberdomide (CC-220) Monotherapy or in Combination with an Anti-CD20 Monoclonal Antibody As Effective Therapy in Patients with Relapsed/Refractory Lymphoma: Early Results from a Phase 1/2 StudyCatherine Thiéblemont, Franck Morschhauser, Javier Muñoz et al.|Blood|2022Cited by 16